Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Malignant neoplasm of pancreas
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2667
|
277
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Adenocarcinoma, Tubular
|
disease |
Neoplasms
|
Neoplastic Process
|
133
|
3
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Carcinoma, Granular Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
116
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Carcinoma, Cribriform
|
disease |
Neoplasms
|
Neoplastic Process
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Adenocarcinoma, Oxyphilic
|
disease |
Neoplasms
|
Neoplastic Process
|
135
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Adenocarcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
123
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Pancreatic Neoplasm
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
764
|
20
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
0.800 |
5 |
|
2001 |
2017 |
Malignant neoplasm of testis
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
253
|
31
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2006 |
Lymphoma, T-Cell, Cutaneous
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
367
|
5
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2002 |
Childhood Synovial Sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
198
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1649
|
88
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hyperglycemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1098
|
108
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Parapsoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant transformation
|
phenotype |
|
Neoplastic Process
|
1027
|
20
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Azoospermia, Nonobstructive
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
91
|
22
|
0.010 |
None |
< 0.001 |
1 |
|
2013 |
2013 |
SVEINSSON CHORIORETINAL ATROPHY
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
139
|
30
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adult Synovial Sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
198
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Pancreatic carcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2689
|
322
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Precancerous Conditions
|
group |
Neoplasms
|
Neoplastic Process
|
471
|
18
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |